Back to Search

BBIO

BridgeBio Pharma, Inc. Common Stock
Data: 2026-09-11
$72.44
Price
-0.08%
Change
$93.42
52W High
$48.78
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options
Analyzing positioning… Options positioning — based on yesterday's biggest open-interest changes See the chart Institutional flows
Track record
signal day → next-day price move
Quick Stats
Sep 11, 2026

57.2

AI Score

HOLD

0.85

Volume Ratio

Nov 04, 2026

Next Earnings

9

+ve Days (30d)

21

-ve Days (30d)

BBIO Price vs Max Options Open Interest

How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.

BBIO Max Change In Options Open Interest

How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.

BBIO Options - Sort by Max open Interest (near term)

12th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

BBIO Daily Out of Money Options - Sort by Max open Interest (near term)

12th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

BBIO Daily In the Money Options - Sort by Max open Interest (near term)

12th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

BBIO Most Active Options by Volume(near term)

12th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track
BBIO Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select an indicator above — it will be added as a pane under the price chart with aligned dates.

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

BBIO Stock Summary

Last updated Sep 11, 2026

BBIO is currently trading at $72.44, positioned below its 200-day moving average of $73.99, suggesting bearish momentum. The stock has a 52-week range of $48.78 to $93.415.

Technical Analysis: The 50-day moving average stands at $80.69, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 29.813, suggesting the stock is oversold and potentially undervalued.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.215, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates BBIO at 57.2/100 with a HOLD recommendation.

BBIO (BridgeBio Pharma, Inc. Common Stock) Indicators

Last updated Sep 11, 2026

Indicator Value
RSI(14) 29.813
CMF (20) -0.215
ROC (10) -7.931
ADX (14) 18.306
Indicator Value
MACD (12,26,9) -1.907
AROONOSC (14) -100.0
WILLAMS %R (14) -95.627
MFI (14) 36.972

BBIO Candlestick Patterns

No validated candlestick patterns fired for BBIO in the last 10 sessions — that's normal. Only the ~15 patterns with a backtested edge (out of 60 textbook patterns) are tracked here.

BridgeBio Pharma, Inc. Common Stock is below both the 50 Day and 200 Day SMA which is considered Bearish.

BBIO Moving Averages Analysis

BBIO (BridgeBio Pharma, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Sep 11, 2026

Days MA
10 75.23
20 78.15
30 79.59
50 80.69
100 74.71
200 73.99

BBIO Fundamental Analysis

P/E (Forward) --
P/E (Trailing) --
Market Cap ($) 14.2 billion
Earnings/Share ($) -3.39
Net Profit Margin (%) -0.9703
Dividend/Share ($) --
EPS Estimate Current Year ($) -2.5843
EPS Estimate Next Year ($) 0.0275
WallStreet Target Price ($) 109.10
Most Recent Quarter

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.